Northern Trust’s Biocept, Inc. BIOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-894
| Closed | -$9.12K | – | 4646 |
|
|
2023
Q1 | $9.12K | Hold |
894
| – | – | ﹤0.01% | 4531 |
|
|
2022
Q4 | $14.2K | Hold |
894
| – | – | ﹤0.01% | 4537 |
|
|
2022
Q3 | $25K | Hold |
894
| – | – | ﹤0.01% | 4513 |
|
|
2022
Q2 | $25K | Sell |
894
-19
| -2% | -$865 | ﹤0.01% | 4591 |
|
|
2022
Q1 | $63K | Buy |
913
+2
| +0.2% | +$157 | ﹤0.01% | 4480 |
|
|
2021
Q4 | $99K | Hold |
911
| – | – | ﹤0.01% | 4430 |
|
|
2021
Q3 | $110K | Sell |
911
-24
| -3% | -$2.8K | ﹤0.01% | 4377 |
|
|
2021
Q2 | $118K | Hold |
935
| – | – | ﹤0.01% | 4325 |
|
|
2021
Q1 | $143K | Buy |
935
+53
| +6% | +$9.62K | ﹤0.01% | 4199 |
|
|
2020
Q4 | $117K | Sell |
882
-40
| -4% | -$5.7K | ﹤0.01% | 4085 |
|
|
2020
Q3 | $122K | Sell |
922
-5
| -0.5% | -$1.01K | ﹤0.01% | 3922 |
|
|
2020
Q2 | $198K | Buy |
927
+777
| +518% | +$111K | ﹤0.01% | 3765 |
|
|
2020
Q1 | $12K | Buy |
150
+78
| +108% | +$7.98K | ﹤0.01% | 4141 |
|
|
2019
Q4 | $6K | Hold |
72
| – | – | ﹤0.01% | 4223 |
|
|
2019
Q3 | $18K | Hold |
72
| – | – | ﹤0.01% | 4162 |
|
|
2019
Q2 | $24K | Hold |
72
| – | – | ﹤0.01% | 4154 |
|
|
2019
Q1 | $25K | Buy |
+72
| New | +$29.2K | ﹤0.01% | 4113 |
|
|
2018
Q3 | – | Sell |
-2
| Closed | -$3K | – | 4343 |
|
|
2018
Q2 | $3K | Hold |
2
| – | – | ﹤0.01% | 4285 |
|
|
2018
Q1 | $5K | Hold |
2
| – | – | ﹤0.01% | 4222 |
|
|
2017
Q4 | $11K | Hold |
2
| – | – | ﹤0.01% | 4190 |
|
|
2017
Q3 | $20K | Hold |
2
| – | – | ﹤0.01% | 4160 |
|
|
2017
Q2 | $23K | Hold |
2
| – | – | ﹤0.01% | 4170 |
|
|
2017
Q1 | $35K | Buy |
+2
| New | +$34K | ﹤0.01% | 4096 |
|
|
2016
Q3 | – | Sell |
-1
| Closed | -$14K | – | 4213 |
|
|
2016
Q2 | $14K | Hold |
1
| – | – | ﹤0.01% | 4139 |
|
|
2016
Q1 | $26K | Hold |
1
| – | – | ﹤0.01% | 4108 |
|
|
2015
Q4 | $28K | Hold |
1
| – | – | ﹤0.01% | 4135 |
|
|
2015
Q3 | $47K | Hold |
1
| – | – | ﹤0.01% | 4085 |
|
|
2015
Q2 | $61K | Hold |
1
| – | – | ﹤0.01% | 4040 |
|
|
2015
Q1 | $48K | Buy |
+1
| New | +$67.2K | ﹤0.01% | 4156 |
|
Other funds holding BIOC
AFM
BFM
TRCT
Northern Trust's BIOC Position: Q2 2023 in Review
Northern Trust sold out of Biocept, Inc. (BIOC) in Q2 2023, closing a stake of 894 shares — an estimated $9.12K sold.
Northern Trust first reported a position in BIOC in Q1 2015 and held it in 29 quarters. The position peaked at $198K in Q2 2020. 11 funds tracked by Wall St. Rank hold BIOC as of Q2 2023.
- Northern Trust reported no remaining Biocept, Inc. position as of Q2 2023 after selling out during the quarter.
- Northern Trust sold 894 Biocept, Inc. shares in Q2 2023, an estimated $9.12K.
- Northern Trust first reported a position in Biocept, Inc. in Q1 2015 and held it in 29 quarters.
- Northern Trust's Biocept, Inc. position peaked at $198K in Q2 2020.
- 11 funds tracked by Wall St. Rank held Biocept, Inc. as of Q2 2023.
Based on Northern Trust's 13F filing for Q2 2023, filed 11 Aug 2023.